CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Sanofi v. Glenmark Pharmaceuticals Inc. USA

1:15-cv-01206

Overview

Case Number 1:15-cv-01206
Filing Date 2015-12-23
Status Terminated
Termination Date 2017-11-07
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Sanofi Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Glenmark Pharmaceuticals Inc. USA Operating Company

Represented By

2 Attorneys Listed

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Sanofi-Aventis U.S. LLC Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Claimant

Glenmark Pharmaceuticals Limited NPE (University / Research)

Represented By

6 Attorneys Listed

Sarah M. Stensland

Email: stensland@ptslaw.com

Jeffer Ali

Email: jali@carlsoncaspers.com

Caroline L. Marsili

Email: cmarsili@carlsoncaspers.com

Alexandra J. Olson

Email: aolson@carlsoncaspers.com

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 16 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (16): πŸ‡ͺπŸ‡Ί Europe FR πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9107900
Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of morality
Filed: 2013-03-19
Issued: 2015-08-18
Active (6.3 yrs remaining)
Expires: 2033-03-19

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 10/14/2016. Amended Pleadings due by 10/14/2...
Entry #16 • 2016-04-01 Document →

Docket Entries

(33 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Glenmark Pharmaceuticals Inc. USA, Glenmark Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1849710.) - filed by Sanofi-Aventis U.S. LLC, Sanofi. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 12/28/2015)

Entry #1 • 2015-12-23
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Glenmark Pharmaceuticals Inc. USA, Glenmark Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1849710.) - filed by Sanofi-Aventis U.S. LLC, Sanofi. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 12/28/2015)

Entry #1 • 2015-12-23
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Glenmark Pharmaceuticals Inc. USA, Glenmark Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1849710.) - filed by Sanofi-Aventis U.S. LLC, Sanofi. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 12/28/2015)

Entry #1 • 2015-12-23
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 12/28/2015)

Entry #2 • 2015-12-23
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/16/2015. Date of Expiration of Patent: 04/16/2029.Thirty Month Stay Deadline: 1/1/2017. (dmp, ) (Entered: 12/28/2015)

Entry #3 • 2015-12-23
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc